A Phase 3 Study of IN10018 in Combination With D-1553 Versus Standard Therapy for First Line Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation
Conditions
Non-Small Cell Lung Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Beijing Cancer Hospital, Beijing, Beijing Municipality, China
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Contact: Study coordinator (Kejing Tang Chief Physician, MD) · tangkj@mail.sysu.edu.cn · 86-13802946566Henan Cancer Hospital, Zhengzhou, Henan, China
Contact: Study coordinator (Huijuan Wang Chief Physician, MD) · 18638561588@163.com · 86-18638561588The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Contact: Study coordinator (Sanxing Guo Chief Physician, MD) · sanxing134@hotmail.com · 86-18337128112Union Hospital Tongji Medidcal College Huazhong University of Science and Technology, Wuhan, Hubei, China
Contact: Study coordinator (Ruiguang Zhang Associate Chief Physician, MD) · zrg27@163.com · 86-15071116896Contact: Study coordinator (Xiaorong Dong Chief Physician, MD)Hunan Cancer Hospital, Changsha, Hunan, China
Contact: Study coordinator (Yongzhong Luo Chief Physician, MD) · luoyongzhong@hnca.org.cn · 86-13607443876Jiangsu Cancer Hospital, Nanjing, Jiangsu, China
First Affiliated Hospital of Gannan Medical University, Gannan, Jiangxi, China
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
Contact: Study coordinator (Longhua Sun Chief Physician, MD) · sunlonghua012024@163.com · 86-18279110112Shanghai Chest Hospital, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Yongfeng Yu Chief Physician, MD)Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Study leads
Zhengbo Song Professor, Doctor
Principal Investigator
Zhejiang Cancer Hospital
Shun Lu Professor, Doctor
Principal Investigator
Shanghai Chest Hospital